Latest News - CRSToday

Thursday, September 14, 2017 | Product Releases

New Medical Marketing Agency Launches

A new health care and medical device marketing agency, Biotica, has launched in Cincinnati. Partners Bill Abramovitz, Susan Abramovitz, and Ben Singleton created Biotica to serve national and inte…

Read the full story

Thursday, September 14, 2017 | Awards

ASCRS Foundation Announces New Chang Humanitarian Award

The American Society of Cataract & Refractive Surgery (ASCRS) Foundation is pleased to announce the creation of the ASCRS Foundation Chang Humanitarian Award. This annual award, which is endowed b…

Read the full story

Thursday, September 14, 2017 | Product Releases

LensFerry Now Offers EHR Integration; Automation Drives Practice Revenue

The digital age has fundamentally changed the marketplace with US online contact lens sales totaling almost $700 million. Giving patients a seamless way to buy lenses from their doctor has become more…

Read the full story

Thursday, September 14, 2017 | Product Releases

Plusoptix Announces the Launch of Its Latest Innovative Vision Screening Device for Pediatric Clinics

Plusoptix announced the launch of its new plusoptiX S16 series, a vision screening device developed especially for the use in pediatric clinics. The plusoptiX S16 is designed to enable pediatricians t…

Read the full story

Wednesday, September 13, 2017 | Health Care

FDA Quality Pilot Aims to Streamline Device Review Process

The FDA is piloting a new scheme for high-risk medical devices that removes the need for preapproval inspections in return for making more information on device quality available early on, according…

Read the full story

Wednesday, September 13, 2017 | Acquisitions/Mergers, Inotek Pharmaceuticals

Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals

Inotek Pharmaceuticals have entered into a definitive merger agreement with Rocket Pharmaceuticals, a US-based gene therapy company. Subject to shareholder approval, the combined company will retain t…

Read the full story

Wednesday, September 13, 2017 | Product Releases, Optovue

Optovue Unveils New AngioVue Essential OCTA at the International Vision Expo

Optovue debuted its AngioVue Essential OCTA capability for optometry and general ophthalmology at the International Vision Expo & Conference 2017 in Las Vegas. AngioVue Essential aids clinician…

Read the full story

Tuesday, September 12, 2017 | Acquisitions/Mergers, PhysIOL sa

PhysIOL Acquires a Majority Stake in Optikon

PhysIOL announced that it has entered into a definitive agreement under which PhysIOL will acquire a majority stake in opthalmic device manufacturer Optikon. Terms of the deal were not disclosed. I…

Read the full story

Tuesday, September 12, 2017 | Medical Studies

OCT Screening Cost-Effective for Diabetic Retinopathy

The use of optical coherence tomography (OCT) to screen everyone with diabetes for retinopathy appears to be a relatively inexpensive way to preserve the quality of life of these patients, results fro…

Read the full story

Monday, September 11, 2017 | Acquisitions/Mergers, Alphaeon

Strathspey Crown to Acquire ShoutMD From Alphaeon Corporation

Strathspey Crown Holdings announced that it has reached an agreement in principle with Alphaeon to acquire the ShoutMD social media platform in its entirety, includi…

Read the full story

Monday, September 11, 2017 | Corporate Lawsuits, Imprimis Pharmaceuticals

Imprimis Releases Statement Regarding Allergan Lawsuit

Imprimis Pharmaceuticals responded to a press release issued by Allergan regarding a lawsuit Allergan USA filed against Imprimis. A portion of the Imprimis statement reads: "Imprimis will aggr…

Read the full story

Friday, September 08, 2017 | Partnerships, Allergan

Allergan Partners With Indian Tribe to Protect Restasis Drug Patents

In an unusual strategy to protect Restasis from generic competition, Allergan announced that is it has sold the drug's patents to an Indian tribe in upstate New York. Allergan and the Saint Reg…

Read the full story

Friday, September 08, 2017 | Corporate Lawsuits, Allergan

Allergan Files Suits Against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida

Allergan USA has filed lawsuits against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida, alleging that those companies are unlawfully manufacturing and selling unapproved new d…

Read the full story

Friday, September 08, 2017 | Medical Studies

US Doctors Unsure Kids Under 3 Need Vision Screening

Children should get their vision tested at least once between ages 3 and 5, but there isn’t enough evidence to say for sure whether they need evaluations when they’re younger, according to…

Read the full story

Thursday, September 07, 2017 | Medical Studies

Researchers at USC Roski Eye Institute Are First to Show LASIK Xtra Does Not Increase Corneal Stiffness Using Brillouin Microscopy

Adding a new data point in the ongoing controversy in ophthalmology surrounding the impact of combined prophylactic corneal cross-linking (CXL) and LASIK flap creation, USC Roski Eye Institute publish…

Read the full story
Load More